Morgan Stanley cuts T. Rowe Price stock price target on AUM decline

Morgan Stanley cut its price target on T. Rowe Price Group to $105 from $107 while keeping an Equalweight rating, citing slightly weaker AUM and flow trends than previously expected. The firm now estimates Q1 2026 EPS at $2.52, up from $2.48, but lowered full-year 2026 and 2027 EPS estimates to $9.67 and $9.57, respectively. T. Rowe also reported $1.71 trillion in AUM as of March 31, 2026 and $13.7 billion in Q1 net outflows, alongside a 2.36% dividend increase to $1.30 per share.

Analysis

The setup is more about the trajectory of franchise economics than the headline AUM print. A mature active manager with persistent outflows can still defend earnings near-term by cutting variable spend, but that only postpones the market’s re-rating problem: if organic decay stays in the low-single-digits, every rally in the equity market can paradoxically worsen the relative burden of passive competition and make fee compression look more structural. The slight upward tweak to near-term EPS is therefore less important than the downward drift in outer-year expectations, which signals analysts are assuming no meaningful operating leverage from market beta alone.

The dividend increase is a useful capital-allocation signal, but it also narrows strategic flexibility at a time when the business likely needs more optionality around alternatives, distribution, and product development. That matters because the path to stabilizing flows is probably not a generic “risk assets up” trade; it requires either genuine product differentiation or a step-up in retirement/wealth channel penetration. Leadership changes in alternatives are directionally supportive, but the second-order effect is that the market will now judge management on whether alternatives can offset core active-equity leakage rather than simply complement it.

The contrarian read is that the stock may not be as cheap as it looks on trailing multiples if the denominator keeps shrinking. A flat multiple on falling forward earnings is not value if the market eventually assigns a lower terminal multiple to a business with low growth and weak flow momentum. The near-term catalyst set is limited unless equity markets remain buoyant long enough for AUM to mask the redemptions; if risk assets wobble, this becomes a faster de-rating story than consensus expects.

Key Decisions for Investors

• Short TROW vs long IWM for 1-3 months: express the view that passive market beta wins over active manager fee pools if outflows persist; target a 5-8% relative move, stop if TROW flow trends improve materially.
• Sell upside in TROW via 3-6 month call spreads around current levels: the stock’s multiple is already discounting a decent amount of stability, while earnings revisions are still drifting down; favorable theta if the name grinds sideways.
• If seeking a long, wait for a broader market drawdown and buy only if TROW trades at a materially lower forward P/E with evidence of flow stabilization; otherwise the risk/reward is poor because earnings quality is still deteriorating.
• Watch alternatives-related peers over the next 2 quarters for signal: if product launches at TROW fail to accelerate inflows, reduce exposure to the whole active-manager basket rather than just this name.